XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (16876)	5/26/2004 10:06:27 AM
From: Edscharp	Read Replies (1) of 17367

Robert, There is probably is no mystery to the Mycoprex issue. It's probably unapprovable just like all the other bpi products that Xoma has put through clinical trials. You did bring up one good point. If Mycoprex was as good as you believe there should be a host of partnerships lining up to help fund clinical trials, but there aren't. I'll make a gentleman's bet with you. Xoma may try to sell Mycoprex to a third party, but they will not partner with anybody to fund Mycoprex trials. It would be like co-owning a legless horse and running it at Belmont. What would be the point? Just my conjecture of course.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next